Related Experiment Videos
The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety
1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98104, USA. roybyrne@u.washington.edu
The Journal of Clinical Psychiatry
|March 15, 2005
Summary
Benzodiazepines target the gamma-aminobutyric acid (GABA)-benzodiazepine receptor complex, crucial in anxiety. Molecular variations in this complex are linked to anxiety disorders and drug responses, suggesting potential therapeutic targets.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- The gamma-aminobutyric acid (GABA)-benzodiazepine receptor complex is central to anxiety pathophysiology.
- Pre-clinical and clinical studies implicate this complex in anxiety disorders.
Purpose of the Study:
- To explore the molecular forms of the GABA-benzodiazepine receptor complex.
- To investigate the link between receptor variations, benzodiazepine actions, and anxiety.
- To understand molecular alterations in relation to human anxiety and drug tolerance.
Main Methods:
- Review of pre-clinical and clinical studies on GABA-benzodiazepine receptor complex.
- Analysis of neuroanatomical distribution of receptors.
- Examination of patient responses to benzodiazepines and receptor density.
Main Results:
- Multiple molecular forms of the GABA-benzodiazepine receptor complex exist, linked to specific benzodiazepine effects.
- Anxious patients exhibit altered responses and reduced receptor numbers in key brain areas.
- Molecular alterations in the receptor complex may mimic human anxiety findings in animals.
Conclusions:
- Genetic variations in the GABA-benzodiazepine receptor complex influence anxiety and drug response.
- Molecular changes in the receptor complex are associated with pathological anxiety and benzodiazepine tolerance.
- Further research into receptor molecular forms could reveal novel anxiety treatment strategies.